title: Cesarean section scar pregnancy treatment--case report.
abstract: This is a case report of a 36-year-old patient with an ectopic pregnancy located in the previous cesarean section scar following in vitro fertilization (IVF). The patient was treated by 50 mg of intrasacular methotrexate locally under ultrasound guidance. Transvaginal ultrasound (TVUS) confirmed that the pregnancy was no longer vital within 24 hours, dilatation and aspiration of the ovular tissue were performed after seven days and it was sent for pathohistological analysis. Eight hours after the procedure, the patient began bleeding abundantly and was consequently treated locally by 1 ml of Beriplast P Combi set, human fibrinogen, and human thrombin set (CSL Behring). After the treatment, the patient was discharged in good health, with normal laboratory values. Her menstrual period resumed 35 days after the procedure.
authors: "Narodni Front" University of Belgrade, School of Medicine, Clinic of Gynecology and Obstetrics, Belgrade, Serbia. lnejkovic@sbb.rs
authors: L
authors: L
authors: Nejković
authors: V
authors: V
authors: Pazin
authors: D
authors: D
authors: Filimonović
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage; D000328:Adult; D002585:Cesarean Section / Q000009:adverse effects; D002921:Cicatrix / Q000473:pathology; D005260:Female; D005307:Fertilization in Vitro / Q000009:adverse effects; D015718:Fibrin Tissue Adhesive / Q000627:therapeutic use; D005340:Fibrinogen / Q000627:therapeutic use; D006470:Hemorrhage / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D013917:Thrombin / Q000627:therapeutic use; D014463:Ultrasonography
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D015718:Fibrin Tissue Adhesive; D005340:Fibrinogen; D013917:Thrombin; D008727:Methotrexate